Open AccessTHE USE OF TRANSEXAMIC ACID FOR TOTAL HIP ARTHROPLASTY IN CHRONIC HEMODIALYSIS PATIENTS
Author(s) -
А. К. Дулаев,
А. Н. Цед,
Н. Е. Муштин
Publication year - 2018
Publication title -
vestnik hirurgii im. i.i. grekova/vestnik hirurgii imeni i.i. grekova
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.136
H-Index - 7
eISSN - 2686-7370
pISSN - 0042-4625
DOI - 10.24884/0042-4625-2018-177-4-47-51
Subject(s) - tranexamic acid , medicine , hemodialysis , traumatology , total hip arthroplasty , orthopedic surgery , surgery , arthroplasty , hip arthroplasty , blood loss , chronic renal failure , renal replacement therapy
The OBJECTIVE is to determine the possibilities of using tranexamic acid for hip arthroplasty in patients receiving renal replacement therapy. MATERIAL AND METHODS. The material for the study was based on the data of 31 patients with pathology of the hip who underwent primary total hip arthroplasty from 2015 to 2017 at the Clinic of Traumatology and Orthopedics of the «Pavlov First Saint Petersburg State Medical University». RESULTS. The study proves the safety of using tranexamic acid for total hip arthroplasty in chronic hemodialysis patients. CONCLUSION. The use of tranexamic acid for hip arthroplasty in patients receiving renal replacement therapy allows to reduce blood loss. The efficacy was 33 % (p<0.05). It is necessary to strictly adhere to the frequency of introduction of tranexamic acid, and dose adjustment depending on the concentration of blood creatinine.